Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-19

Clinical Trial Update: Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating telmisartan added to ART during acute HIV infection to reduce CNS reservoirs and lymph node fibrosis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ART (antiretroviral therapy) (antiretroviral therapy)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: SEARCH Research Foundation | Conditions: Acute HIV Infection, HIV CNS Involvement | Phase 2 | Status: COMPLETED